Updated Results on Modakafusp Alfa (TAK-573) Safety and Efficacy; Phase 1/2 Study of RRMM Patients

Abstract Book for the 27th Congress of the European Hematology

Updated Results on Modakafusp Alfa (TAK-573) Safety and Efficacy

Updated Results on Modakafusp Alfa (TAK-573) Safety and Efficacy

Current Status of Novel Agents for the Treatment of B Cell

Cancers, Free Full-Text

Efficacy and Safety of Tocilizumab for the Treatment of Systemic

Diagnosis and Therapeutic Advances in Multiple Myeoma

Diagnosis and Therapeutic Advances in Multiple Myeoma

Bimekizumab Maintains Improvements in Efficacy Endpoints and Has a

TAK-573 - Modakafusp alfa - Multiple Myeloma Clinical Trials

Long-term efficacy and safety of alemtuzumab in patients with RRMS

Diagnosis and Therapeutic Advances in Multiple Myeoma

Moving Through a Crowded Space: Where Do Emerging Immunotherapies